The "Global Healthcare Licensing: Annual Trends" report has been added to ResearchAndMarkets.com's offering.

Japan, US and Europe are the world's largest healthcare markets. Patients in these regions have comparable buying power and can rely on widely available and high quality healthcare products. As more and more progress in the life sciences sector occurs by a combination of different technologies, the growth of agreements implying activities of R&D as well as licensing for co-promoting and co-marketing has been strong. These licensing arrangements influence healthcare markets and are therefore an important factor for consideration for companies for their healthcare investments.

This capstone research report covers all such licensing deals and negotiations that take place between healthcare companies of Japan, US and Europe every year. Furthermore, the licensing deals and negotiations that take place between healthcare companies of other select regions with Japan, US and Europe as well as among the healthcare companies of Japan, US, Europe, and other select regions every year are also studied and included. All this collected data is comprehensively analyzed to understand the licensing trends and directions during each year in the healthcare sector.

Key features:

  • 12 months' Japan-US-Europe healthcare licensing transactions in one place
  • 12 months' other select regions healthcare licensing transactions at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Licensing regulatory news updates
  • Canada/Australia/NZ licensing trends with Japan-US-Europe covered
  • Emerging markets licensing trends with Japan-US-Europe covered
  • Licensing trends among Japan, US, Europe, and other select regions covered
  • Licensing trends and directions summarized

The report is useful to:

  • Japan, US and Europe healthcare companies planning to introduce products in each other's markets
  • Healthcare companies of select other regions planning to introduce products in Japan, US and European markets
  • Select other regions' healthcare companies planning to introduce products in each other's markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals

For more information about this report visit https://www.researchandmarkets.com/research/7t6sq3/annual_trends_in?w=4